Key points are not available for this paper at this time.
A study has been made of the survival times of 100 terminal cancer patients who were given supplemental ascorbate, usually 10 g/day, as part of their routine management and 1000 matched controls, similar patients who had received the same treatment except for the ascorbate. The two sets of patients were in part the same as those used in our earlier study [Cameron, E. 8 of the ascorbate-treated patients are still alive, with a mean survival time after untreatability of 3.5 yr.
Cameron et al. (Fri,) studied this question.